http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02072105-A9

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2692966f2e618e16cbe978b308756bce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdd619b8a2cc2f110b9ee4dc8d896a17
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5575
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5575
filingDate 2002-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac8b9b2dabcca5526412f3abfff44b88
publicationDate 2004-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-02072105-A9
titleOfInvention Improved prostanoid therapies for the treatment of glaucoma
abstract Compositions and methods for the treatment of glaucoma and/or ocular hypertension in humans utilizing improved doses of certain prostaglandin derivatives and analogs are disclosed.
priorityDate 2001-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5977
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483965
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420120
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311027
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226414136
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280883
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7409
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396808
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281056
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33624
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226471523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID643460
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453671681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282226
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452892474
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502070
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13020083
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412773
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377

Total number of triples: 58.